Understanding the link between COVID-19 and diabetes
Amid the many problems posed by the pandemic, one positive outcome is that COVID-19 is providing valuable insights that could help researchers unlock the secrets of another intractable disease: diabetes.
Why does pollen make you miserable? Here`s why it triggers allergiesand some tips
Allergies in general—whether it be to food, pets or pollen—occur when the body's immune system "sees a substance as harmful and overreacts to it," according to the asthma and allergy foundation of america.
Energy-burning brown fat less active in boys with obesity
A study at McMaster University has found that brown adipose tissue (BAT) is less active in boys with obesity compared to boys with a normal body mass index (BMI).
How Much You Should Exercise for a Healthy Heart
Whether you walk around the block or swim 20 laps each morning, there are lots of good reasons to exercise. It helps you feel energized and lessens your stress, but it’s your heart that reaps the most benefits when you get moving.
Obesity `accelerates` COVID-19 mortality risk amongst ethnic minorities
A stronger association exists between deaths from COVID-19 and obesity in people of Black, South Asian and other ethnic minority groups than in White people, latest research published in the journal Nature Communications demonstrates.
While understanding causes of cardiovascular diseases, not everyone recognizes their own risks
Although many people know what increases the risk of cardiovascular diseases, such as heart attacks, not everyone recognizes their own risk factors. This is shown by a new study of 423 Swedes aged 40–70 years, which has now been published in the scientific journal Preventive Medicine Reports.
Weight loss reduces the risk of growths linked to colorectal cancer
A new paper in JNCI Cancer Spectrum, published by Oxford University Press, indicates that overweight and obese people who lose weight may reduce their chances of later developing colorectal adenoma—a type of benign growth or polyp in the colon or rectum that could lead to colorectal cancer.
Semaglutide superior to liraglutide for weight loss
Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous liraglutide, according to a study published in the Jan. 11 issue of the Journal of the American Medical Association.